News

August 14, 2020

Conventions & Events ›


Register to the Upcoming Live Webinar on Continuous & Remote Respiratory Monitoring with Hexoskin

The introduction of digital technologies has promulgated innovative platforms aimed at reducing the gaps in respiratory disease management and research. How are they used? How can we distinguish effective programs from the hundreds of available digital solutions? This webinar will discuss the benefits and considerations of digital technologies for Healthcare Providers, Researchers and Patients, and provide real-world evidence of Hexoskin's remote respiratory monitoring capabilities.

Join us with our guest speakers on Tuesday, August 25, 2020, at 11:00 AM (EDT), for the upcoming Hexoskin Live Webinar on Continuously & Remote Respiratory Monitoring. If you are unable to attend, you can still register and we will send you the recorded webinar by email afterwards. 

Register today to reserve your spot!

Guest Speakers: 

  • Dr. Dennis Jensen: 
    Associate Professor, Department of Kinesiology & Physical Education, at McGill University.
    Dennis Jensen's research focuses on identifying the causes of activity-related breathing discomfort (dyspnea) and exercise intolerance in health, variants of health (e.g., elderly, obesity) and in patients with chronic cardiorespiratory disease, specifically chronic obstructive pulmonary disease.
    (Source: https://rimuhc.ca/-/dennis-jensen-phd)

  • Denise Mannée: 
    PhD Candidate & Technical Physician, Department of Pulmonology, at Radboundumc University.
    Denise Mannée was born in Amersfoort, Utrecht, The Netherlands in 1992. She received B.S. and M.S. degree in Technical Medicine from the University of Twente in 2013 and 2017. She is currently pursuing a Ph.D. degree in medicine at the Radboud University Medical Centre, Nijmegen, Gelderland, The Netherlands. Since 2017, she was a junior researcher at the Radboud University Medical Centre, Nijmegen, Gelderland, The Netherlands. Her research interest includes lung physiology, the development of home monitoring devices and improvement of patient care.

Moderator:

  • Maria Athanassiou: Medical Science Liaison at Hexoskin

 

 We look forward to your presence for this special event!

August 12, 2020

research ›


White Paper: A comparative Perspective on Wearables Key Features for Advanced Respiratory Monitoring



Over the last few weeks, the global number of confirmed cases of COVID-19 has dramatically increased, leading to critically elevated hospitalization rates and emergency room overcrowding [1]. Shortage of beds and equipment in addition to staff exhaustion are aggravating the already fragile and precarious situation in hospitals [2–4]. This setting has created an unprecedented strain on healthcare systems, thereby compromising the quality of patient care [2,4]. Despite the concerted efforts of scientists and clinicians to find an effective vaccine, this health crisis will likely persist longer than expected [5]. Therefore, all efforts should be directed to confirm and deploy approaches to relieve healthcare systems before they crumble under pressure [3,4,6,7]. One such strategy is the early recognition of clinical deterioration, which limits the spread of the disease and reduces unnecessary hospital demands [4].

A growing body of evidence supports the clinical relevance of respiratory rate (RR) as a key predictor for adverse health outcomes [8–11]. In patients affected by COVID-19, an increase of RR can be a warning sign for patient deterioration and criteria for ICU transfer [12]. Massaroni et al. suggested that the current situation has ironically generated the perfect conditions for wearables to demonstrate their worth and capabilities to alleviate caregivers’ workload in this time of crisis. According to the authors, digital health respiratory monitoring technologies can provide relevant data to facilitate effective remote triage, diagnosis and symptoms monitoring. This will positively impact care assistance for self-isolated patients [13]. A wide variety of technologies for RR monitoring have been developed, tested and are commercially available [14–16]. However, these portable health technologies are not all comparable in terms of design, validity and usability [14–19].

Hexoskin stands out against other contenders in the respiratory field as a result of its strong presence in research publications, but also in consequence of the clinical validation of its biometric data [14,16]. Hexoskin supports professionals & researchers to improve their standards of care and research by providing cutting edge health sensors, and state-of-the-art health data management & analysis software.

To learn more about Hexoskin’s digital health solutions for RR monitoring, we invite you to download our latest White Paper titled: A comparative Perspective on Wearables Key Features for Advanced Respiratory Monitoring. In this White Paper, we explore:

  • The speculative world of emerging respiratory monitoring technologies.
  • The key features for advanced respiratory monitoring.
  • Hexoskin’s unique capabilities to remotely monitor respiratory volumes and patterns through rich and high-resolution respiratory data integrated with the Hexoskin’s end-to-end platform (i.e. interoperable software solutions, secure and private infrastructure and machine learning services) to support research and professional organizations.

References:

  1. World Health Organization. Coronavirus disease (COVID-19) Situation Report-197. 2020.
  2. Mishra S. Hospital overcrowding. Western Journal of Medicine 2001 ; 174 : 170–170.
  3. Shoukat A, Wells CR, Langley JM, et al. Projecting demand for critical care beds during COVID-19 outbreaks in Canada. CMAJ 2020 ; 192 : E489–E496.
  4. Whiteside T, Kane E, Aljohani B, et al. Redesigning emergency department operations amidst a viral pandemic. The American Journal of Emergency Medicine 2020 ; 38 : 1448–1453.
  5. Adhanom Ghebreyesus T. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 3 August 2020. 2020.
  6. Government of Canada. The “smart shirts” helping reduce the pressure COVID-19 is putting on hospitals. 2020.
  7. Verelst F, Kuylen E, Beutels P. Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020. Eurosurveillance 2020 ; 25.
  8. Cretikos MA, Bellomo R, Hillman K, et al. Respiratory rate: the neglected vital sign. Medical Journal of Australia 2008 ; 188 : 657–659.
  9. Garrido D, Assioun JJ, Keshishyan A, et al. Respiratory Rate Variability as a Prognostic Factor in Hospitalized Patients Transferred to the Intensive Care Unit. Cureus 2018.
  10. Keshvani N, Berger K, Gupta A, et al. Improving Respiratory Rate Accuracy in the Hospital: A Quality Improvement Initiative. J Hosp Med 2019 ; 14 : 673–677.
  11. Van Diest I, Thayer JF, Vandeputte B, et al. Anxiety and respiratory variability. Physiology & Behavior 2006 ; 89 : 189–195.
  12. Sun Q, Qiu H, Huang M, et al. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann. Intensive Care 2020 ; 10 : 33.
  13. Massaroni C, Nicolò A, Schena E, et al. Remote Respiratory Monitoring in the Time of COVID-19. Front. Physiol. 2020 ; 11 : 635.
  14. Khundaqji H, Hing W, Furness J, et al. Smart Shirts for Monitoring Physiological Parameters: Scoping Review. JMIR Mhealth Uhealth 2020 ; 8 : e18092.
  15. Massaroni C, Nicolò A, Lo Presti D, et al. Contact-Based Methods for Measuring Respiratory Rate. Sensors 2019 ; 19 : 908.
  16. Soon S, Svavarsdottir H, Downey C, et al. Wearable devices for remote vital signs monitoring in the outpatient setting: an overview of the field. BMJ Innov 2020 ; 6 : 55–71.
  17. Aliverti A. Wearable technology: role in respiratory health and disease. Breathe 2017 ; 13 : e27–e36.
  18. Düking P, Hotho A, Holmberg H-C, et al. Comparison of Non-Invasive Individual Monitoring of the Training and Health of Athletes with Commercially Available Wearable Technologies. Front. Physiol. 2016 ; 7.
  19. Peake JM, Kerr G, Sullivan JP. A Critical Review of Consumer Wearables, Mobile Applications, and Equipment for Providing Biofeedback, Monitoring Stress, and Sleep in Physically Active Populations. Front. Physiol. 2018 ; 9 : 743
    July 14, 2020


    Hexoskin Smart BLE Demo - Now Available on All Operating Systems

    We are now making the Hexoskin Smart BLE Demo widely available for development across all Bluetooth enabled operating systems. Our community of developers can now retrieve Hexoskin's Data Channels in real time, with remote access through our open API.

    Compatible with the Hexoskin Smart Device - Bluetooth 4.1 interface, the Hexoskin Smart BLE Demo is OS agnostic and now available for development on all operating systems including Mac, Windows, Linux, Raspberry Pi, Android, iOS.

    We invite you to visit our Developer page to learn more about Hexoskin data integration solutions, developer tools and documentation available.

    To request access for your project please contact the Hexoskin API team: api@hexoskin.com

    July 06, 2020


    European Connected Health Alliance Pop-Up: Hexoskin's CEO Presents New Ways of Keeping Chronic Cardiac and Pulmonary Diseases Patients Safe at Home during the COVID-19 Pandemic.

    As countries are affected by COVID-19, populations are being asked to self-isolate and prevent the spread of the virus in Europe and Canada. For instance, patients suffering from cardiac, and lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) are among the most vulnerable to infections, including the Coronavirus disease (SARS-CoV-2). However, it is well documented that social isolation among older adults is a serious public health concern due to its impacts on physical and mental health.

    This European Connected Health Alliance Pop Up looks at ways that Canada and Europe can connect in areas they have collaborated previously such as healthy ageing to find common lessons and solutions. 

    On Thursday, July 2nd, Hexoskin's CEO and co-founder, Pierre-Alexandre Fournier attended the Pop-Up Ecosystem “Canada and Europe Tackle COVID-19 and Isolationfrom European Connected Health Alliance. Our CEO talked about new ways of keeping chronic pulmonary and cardiac diseases patients safe at home during the COVID-19 pandemic. See minute 47:00 in the video.

    (Source: ECHAlliance, 2020)

     

    With over 85 scientific publications & validation studies published since 2012, Hexoskin is the solution of choice to generate precise physiological health data. Hexoskin’s team of experts supports researchers and investigating teams to design and manage their multi-sites studies.

    Request an e-meeting with our team to discuss your needs and learn more about how Hexoskin can support remote patient-centered studies.

    July 03, 2020


    SENSORIA 6 Mars Mission: Long Duration Mars Analog Simulations using Hexoskin

    HI-SEAS (Hawai’i Space Exploration Analog and Simulation) is a Habitat on an isolated Mars-like site on the Mauna Loa side of the saddle area on the Big Island of Hawaii at approximately 8200 feet above sea level. HI-SEAS not only offers physical isolation but also geological and environmental similarities to Mars.

    The Sensoria Mars Mission took place from January 4-18, 2020 in Hawaii, on the remote slopes of Mauna Loa, the largest volcano in the world, six scientists embarked on a novel "mission to Mars."

    Analog astronaut missions place scientists and explorers in remote locations on Earth that physically resemble cosmic destinations like the moon and Mars. There, the researchers explore and perform research as if they were in space. This both generates important scientific data and informs space agencies about what it might be like to step foot on those far-off hostiles surfaces. 

    The Sensoria program is unique for a number of reasons, but one that stands is that this is the first HI-SEAS crew to consist of all women. 

    «There is an imperative to advance the female narrative within human space exploration and this high-visibility, high-impact mission places women squarely at the center of a shared vision for the future». Sensoria-6 Mars Mission. 

    Congratulations to the SENSORIA Team for this great mission!
     

    Are you working on a project where you believe our technologies would suit your needs in monitoring health vitals on earth and in Space? Contact us to discuss your objectives and see how Astroskin or Hexoskin could be useful! 

    June 10, 2020


    Continuity of respiratory care during COVID-19 - Continuous Respiratory Monitoring with Hexoskin

    Patients suffering from lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) are among the most vulnerable to infections, including the Coronavirus disease (SARS-CoV-2). In fact, they are more likely to develop severe disease or to be admitted to intensive care units (ICU) when compared to patients with conditions like high blood pressure or diabetes (Jain et al. 2020). COPD patients also have a 5 fold greater risk of developing complications when contracting SARS-CoV-2 (Lippi et al. 2020). In fact, COPD patients are at risk of developing a more severe form of SARS-CoV-2 leading to serious complications (Attaway et al. 2020). Overall, the care management may turn out to be far more complicated for these patients (Tal-Singer et al. 2020).

    The importance of ensuring continuity of care for lung diseases & COPD Patients

    The number of COPD patients has been on the rise for several decades already and are projected to keep increasing (Adeloye et al. 2015; GlobalData 2018; Ma et al. 2015). Comorbidities and complications associated with this chronic condition make this the highest financial burden on the healthcare system (Chapman et al. 2006; Ford et al. 2015). In the current COVID-19 context, these costs may increase dramatically.

    This alarming rate of COPD patients requiring continuous and expensive medical care is now combined with the pressure faced by Healthcare systems to tackle  the COVID-19 pandemic. It has become essential to think of cost-effective tools such as connected health platforms and telemedicine services for assisting and monitoring these patients at home (Tal-Singer et al. 2020). It was even reported that some COPD patients were misdiagnosed for SARS-CoV-2,  thus delaying proper care and putting them in a precarious situation (Tal-Singer et al. 2020). Imperative actions must be implemented to closely monitor all COPD patients, ensure the continuity of their care and prevent disease progression, exacerbations and further harm. Acting early and effectively towards this most vulnerable population will be the key to good clinical outcomes and lower medical costs for the healthcare system.

    Throughout the COVID-19 pandemic, Hexoskin remains committed to providing complete connected health solutions for remote patient monitoring, thereby promoting efficient and valuable continuity of care. Hexoskin is the only clinically validated garment able to provide continuous vital signs monitoring and has already been widely used in both clinical and scientific research settings (over 85 scientific publications). Integrating new and innovative technologies such as Hexoskin into the basic care of patients with chronic respiratory diseases will ensure an enhanced and continuous assessment of their health condition, and this, at all times.

    Figure 1. Optimizing patient care with continuous monitoring with Hexoskin.

    How to remotely and continuously monitor patients with respiratory diseases & COPD with Hexoskin?

    To learn more about how to remotely and continuously monitor patients with respiratory diseases & COPD with Hexoskin, we invite you to download our latest White Paper. In this White Paper, you will learn more about: 

    • Hexoskin’s unique capabilities to continuously monitor, not only respiratory rate, but the overall respiratory function.
    • Easing patient burden and improving their overall experience outcome using the Hexoskin Remote Monitoring Platform
    • How Hexoskin telemonitoring solution for COPD patients and other respiratory diseases contribute to Patient empowerment and improvement of Quality of Life.

     

    Join us this week at #BIODigital International Convention 2020!

    Hexoskin is thrilled to attend once again the upcoming BIODigital International Convention 2020, and connect with other members of the life science community. This year the meetings will transition to a virtual event format in which Hexoskin will take part. Pierre-Alexandre Fournier, co-founder, and CEO of Hexoskin will speak on the panel:

    Can AI Prevent Epidemics? (Available on demand).

    The panel is hosted by Annastasiah Mudiwa Mhaka, PhD, Co-founder and Convenor of the Alliance for Artificial Intelligence in Healthcare (AAIH) Convenor, former President; Founder; Mawambo Lifesciences. Our CEO will be joined in this panel by leaders in government, technology, venture capital, and health care to discuss the potential for using AI to protect us from the next pandemic or superbug. The world is more vulnerable than ever to outbreaks and remains ill-prepared to predict, prevent, detect, and respond to a significant pandemic. The panel will cover how advancements in artificial intelligence (AI) and machine learning (ML) tools and algorithms can improve the prediction of infectious disease outbreaks and prevent them from causing devastating pandemics. The panel participants will also discuss the kind of innovative public-private partnerships that can be used to develop and test new AI tools for epidemic prevention. 

    Hexoskin will also demonstrate how the industry can leverage Hexoskin sensors, clinical solutions, and AI to fulfill the increasing demand for real-world evidence. Pharma and CROs interested in digital biomarkers are invited to reach out to our team to get insights on how clinical-grade wearable sensors and AI software can facilitate remote trials and monitor patients from home.

    A CONNECTED HEALTH PLATFORM BUILT AROUND
    YOU AND THE PATIENT

    Hexoskin is the world leader in smart clothing and body sensing technologies.

    The Hexoskin Connected Health Platform is the fastest growing platform available to collect Real World Evidence and publish results. Hexoskin is the leading clinically validated solution that collects continuously precise ECG, Respiratory & Activity & Sleep data.

    Thousands of professionals, researchers, and students from universities, research institutions, colleges, and private organizations are leveraging the precise data collected by our comfortable and non-invasive Smart Garments. Our clients appreciate our accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, analyze, and export raw & processed data.

    With over 85 scientific publications & validation studies published since 2012, Hexoskin is the solution of choice to generate precise physiological health data. Hexoskin’s team of experts supports researchers and investigating teams to design and manage their multi-sites studies.

    Request an e-meeting with our team to discuss your needs and learn more about how Hexoskin can support remote patient-centered studies. 

    March 26, 2020

    Connected Health › COVID-19 ›


    Hexoskin to Support Medical Research and Covid-19 Response

    Since the beginning of March, Hexoskin has been working with governements and health systems in the US and Canada to define actions to support healthcare services during the COVID-19 response.

    We are currently putting in place patient monitoring programs in hospitals and at home for COVID-19 patients. These projects are important to support telehealth services, but also to gather data for medical research and manage the public response to the virus. We are now working on onboarding our first COVID-19 patients.

    The data collected will also be used to develop AI/machine learning software to better assess the risk of COVID-19 patients recovering at home. Hexoskin biometric shirts can continuously measure respiration effort in addition to cardiac activity, which provides unique data to understand the evolution of the disease and its effects on lung function.

    We are also working with health systems on rapidly setting up programs to ensure the continuity of care for patients currently enrolled in cardiac and pulmonary rehabilitation programs with online tools.

    We understand that hospitals are currently focused 100% on hospitalized patients, that's why Hexoskin is setting up telehealth teams of its own and offering these resources to support these programs and complement health systems' resources.

    If you are looking for help for telehealth programs or COVID-19 home monitoring programs please contact us today: contact@hexoskin.com / 1-888-887-2044

    Hexoskin Celebrates Pulmonary Rehabilitation Week

    Today, we start celebrating Pulmonary Rehabilitation Week. At Hexoskin, we think that Pulmonary Rehabilitation (PR) is vital and we are happy to celebrate all the efforts of the professionals and also the people who are following a PR. Pulmonary Rehabilitation programs have demonstrated health benefits and can positively improve the quality of life of people living with lung diseases.

    If you have moderate to very severe Chronic obstructive pulmonary disease (COPD), you're probably eligible for pulmonary rehab. Ask your physician if there's a program near you.

    For healthcare professionals, did you know that PR referrals & access are still very limited? According to a recent study, only 3% of Medicare beneficiaries with COPD are currently enrolled (Garvey et al. 2019). You can do your part by educating your peers, colleagues, and administrators about the benefits of PR.

    For more information, visit the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) Website: https://www.aacvpr.org/Events-Education/Live-Workshops/Cardiac-Pulmonary-Rehabilitation-Weeks

    #PRWeek20

    February 25, 2020


    Hexoskin: The Leading Platform for Health Research. Get 10% OFF + FREE SHIPPING Today!

    With over 83 scientific publications, the Hexoskin Connected Health Platform is the fastest growing platform available to collect Real World Evidence and publish results. Hexoskin is the only clinically validated solution that collects continuously precise ECG, Respiratory & Activity & Sleep data.

    Thousands of professionals, researchers, and students from universities, research institutions, colleges, and private organizations are leveraging the precise data collected by our comfortable and non-invasive Smart Garments. Our clients appreciate our accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, analyze, and export raw & processed data.



    Get 10% OFF + FREE SHIPPING on Your Hexoskin Order

    For a limited time*, Hexoskin offers a 10% Discount and FREE Shipping* on all Hexoskin Smart Garments & Kits. To order, contact sales@hexoskin.com or call our Sales team at 1 888-887-2044. Mention the code HEXOPRO to qualify for the discount.

    This is a limited time offer* only valid until March 31, 2020, at 11:59 PM (EST). 

    About Hexoskin:
    Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.

    The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 80 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning.

    Liquid error: Could not find asset snippets/newsletter-popup.liquid